Shaitelman, Simona F;
Anderson, Bethany M;
Arthur, Douglas W;
Bazan, Jose G;
Bellon, Jennifer R;
Bradfield, Lisa;
Coles, Charlotte E;
Gerber, Naamit K;
Kathpal, Madeera;
Kim, Leonard;
Laronga, Christine;
Meattini, Icro;
Nichols, Elizabeth M;
Pierce, Lori J;
Poppe, Matthew M;
Spears, Patricia A;
Vinayak, Shaveta;
Whelan, Timothy;
Lyons, Janice A.
This guideline provides evidence-based recommendations on appropriate indications and techniques for partial breast irradiation (PBI) for patients with early-stage invasive breast cancer and ductal carcinoma in situ.
ASTRO convened a task force to address 4 key questions focused on the appropriate indic...
Evidence-based recommendations on trastuzumab deruxtecan (Enhertu) for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 treatments in adults.
Commercial arrangement
There is a managed access agreement, which includes a patient access scheme, for trastuzumab derux...
This guideline covers care for people with a family history of breast, ovarian or another related (prostate or pancreatic) cancer. It aims to improve the long-term health of these families by describing strategies to reduce the risk of and promote early detection of breast cancer (including genetic testi...
This guideline covers diagnosing and managing early and locally advanced breast cancer....
This guideline covers care and support for people with advanced (stage 4) breast cancer. It aims to help them and their healthcare professionals make shared decisions about tests and treatments to improve outcomes and quality of life. A table of NHS England interim treatment regimens gives possible alter...
PURPOSE: The current incidence of cancer in the world is 14 million cases in 2012, with a mortality rate of 8.2 million in that year. The incidence of cancer in Spain exceeds 215,000 cases a year, and survival rates are the highest when compared to those of our neighbouring countries. Among the reasons f...
Every year, breast cancer kills more than 500,000 women around the world. In resource-poor settings, a majority of women with breast cancer are diagnosed at an advanced stage of disease; their five-year survival rates are low, ranging from 10-40%. In settings where early detection and basic treatment are...